BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 17324406)

  • 21. HIV entry inhibitor TAK-779 attenuates atherogenesis in low-density lipoprotein receptor-deficient mice.
    van Wanrooij EJ; Happé H; Hauer AD; de Vos P; Imanishi T; Fujiwara H; van Berkel TJ; Kuiper J
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2642-7. PubMed ID: 16239591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-6 positively regulates Foxp3+CD8+ T cells in vivo.
    Nakagawa T; Tsuruoka M; Ogura H; Okuyama Y; Arima Y; Hirano T; Murakami M
    Int Immunol; 2010 Feb; 22(2):129-39. PubMed ID: 20042455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of CCR5 in the passage of Th1-type cells across the blood-retina barrier in experimental autoimmune uveitis.
    Crane IJ; Xu H; Wallace C; Manivannan A; Mack M; Liversidge J; Marquez G; Sharp PF; Forrester JV
    J Leukoc Biol; 2006 Mar; 79(3):435-43. PubMed ID: 16365158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue trafficking patterns of effector memory CD4+ T cells in rheumatoid arthritis.
    Zhang X; Nakajima T; Goronzy JJ; Weyand CM
    Arthritis Rheum; 2005 Dec; 52(12):3839-49. PubMed ID: 16329093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-derived chemokine CCL5 enhances TGF-β-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells.
    Chang LY; Lin YC; Mahalingam J; Huang CT; Chen TW; Kang CW; Peng HM; Chu YY; Chiang JM; Dutta A; Day YJ; Chen TC; Yeh CT; Lin CY
    Cancer Res; 2012 Mar; 72(5):1092-102. PubMed ID: 22282655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection.
    Ward SM; Fox BC; Brown PJ; Worthington J; Fox SB; Chapman RW; Fleming KA; Banham AH; Klenerman P
    J Hepatol; 2007 Sep; 47(3):316-24. PubMed ID: 17475362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD4+CD25+ regulatory T cells in the small intestinal lamina propria show an effector/memory phenotype.
    Guo Z; Jang MH; Otani K; Bai Z; Umemoto E; Matsumoto M; Nishiyama M; Yamasaki M; Ueha S; Matsushima K; Hirata T; Miyasaka M
    Int Immunol; 2008 Mar; 20(3):307-15. PubMed ID: 18184698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M; Piccirillo CA
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Commensal bacteria and expression of two major intestinal chemokines, TECK/CCL25 and MEC/CCL28, and their receptors.
    Meurens F; Berri M; Siggers RH; Willing BP; Salmon H; Van Kessel AG; Gerdts V
    PLoS One; 2007 Jul; 2(7):e677. PubMed ID: 17653288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic effect of CXCR3-expressing regulatory T cells on liver, lung and intestinal damages in a murine acute GVHD model.
    Hasegawa H; Inoue A; Kohno M; Lei J; Miyazaki T; Yoshie O; Nose M; Yasukawa M
    Gene Ther; 2008 Feb; 15(3):171-82. PubMed ID: 17989707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CCR7 mediates the migration of Foxp3+ regulatory T cells to the paracortical areas of peripheral lymph nodes through high endothelial venules.
    Ueha S; Yoneyama H; Hontsu S; Kurachi M; Kitabatake M; Abe J; Yoshie O; Shibayama S; Sugiyama T; Matsushima K
    J Leukoc Biol; 2007 Nov; 82(5):1230-8. PubMed ID: 17698914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CXCR3 is required for migration to dermal inflammation by normal and in vivo activated T cells: differential requirements by CD4 and CD8 memory subsets.
    Mohan K; Cordeiro E; Vaci M; McMaster C; Issekutz TB
    Eur J Immunol; 2005 Jun; 35(6):1702-11. PubMed ID: 15884054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RANK-RANKL signaling pathway is critically involved in the function of CD4+CD25+ regulatory T cells in chronic colitis.
    Totsuka T; Kanai T; Nemoto Y; Tomita T; Okamoto R; Tsuchiya K; Nakamura T; Sakamoto N; Akiba H; Okumura K; Yagita H; Watanabe M
    J Immunol; 2009 May; 182(10):6079-87. PubMed ID: 19414759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
    Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
    Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CCR5 and CXCR3 are dispensable for liver infiltration, but CCR5 protects against virus-induced T-cell-mediated hepatic steatosis.
    Holst PJ; Orskov C; Qvortrup K; Christensen JP; Thomsen AR
    J Virol; 2007 Sep; 81(18):10101-12. PubMed ID: 17626099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of CCR5/CXCR3 expressing CD8+ cells in liver damage and viral control during persistent hepatitis C virus infection.
    Larrubia JR; Calvino M; Benito S; Sanz-de-Villalobos E; Perna C; Pérez-Hornedo J; González-Mateos F; García-Garzón S; Bienvenido A; Parra T
    J Hepatol; 2007 Nov; 47(5):632-41. PubMed ID: 17560677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of CC chemokines in gammadelta T lymphocyte trafficking during allergic inflammation: the role of CCL2/CCR2 pathway.
    Penido C; Costa MF; Souza MC; Costa KA; Candéa AL; Benjamim CF; Henriques Md
    Int Immunol; 2008 Jan; 20(1):129-39. PubMed ID: 18056919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-5 participates in the pathogenesis of ileitis in SAMP1/Yit mice.
    Takedatsu H; Mitsuyama K; Matsumoto S; Handa K; Suzuki A; Takedatsu H; Funabashi H; Okabe Y; Hara T; Toyonaga A; Sata M
    Eur J Immunol; 2004 Jun; 34(6):1561-9. PubMed ID: 15162425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blockade of PSGL-1 attenuates CD14+ monocytic cell recruitment in intestinal mucosa and ameliorates ileitis in SAMP1/Yit mice.
    Inoue T; Tsuzuki Y; Matsuzaki K; Matsunaga H; Miyazaki J; Hokari R; Okada Y; Kawaguchi A; Nagao S; Itoh K; Matsumoto S; Miura S
    J Leukoc Biol; 2005 Mar; 77(3):287-95. PubMed ID: 15569697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice.
    Veillard NR; Kwak B; Pelli G; Mulhaupt F; James RW; Proudfoot AE; Mach F
    Circ Res; 2004 Feb; 94(2):253-61. PubMed ID: 14656931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.